Lameck Mbangula Amugongo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lameck Mbangula Amugongo has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Jan Seidel
Biostatistics and Data Sciences Department, Boehringer Ingelheim Pharma GmbH \& Co. KG, Birkendorfer Str. 65, Biberach an der Riß, 88400, Germany., Germany
1 shared publication - Pietro Mascheroni
Boehringer Ingelheim Pharma GmbH & Co. KG
1 shared publication - Stefan Doering
Biostatistics and Data Sciences Department, Boehringer Ingelheim Pharma GmbH \& Co. KG, Birkendorfer Str. 65, Biberach an der Riß, 88400, Germany., Germany
1 shared publication - Steven Geoffrey Brooks
Biostatistics and Data Sciences Department, Boehringer Ingelheim (China) Investment Co., Ltd, Shanghai, China., China
1 shared publication
Latest Publications
- Open Access
- 11 July 2024
- Published by MDPI AG in Preprints.org
Retrieval Augmented Generation for Large Language Models in Healthcare: A Systematic Review
Large Language Models (LLMs) have demonstrated promising capabilities to solve complex tasks in critical sectors such as healthcare. However, LLMs are limited by their training data which is often outdated, the tendency to generate inaccurate ("hallucinated") content and a lack of transparency in the content they generate. To address these limitations, retrieval augmented generation (RAG) grounds the responses of LLMs by exposing them to external knowledge sources. However, in the healthcare domain there is currently a lack of systematic understanding of which datasets, RAG methodologies and evaluation frameworks are available. This review aims to bridge this gap by assessing RAG-based approaches employed by LLMs in healthcare, focusing on the different steps of retrieval, augmentation and generation. Additionally, we identify the limitations, strengths and gaps in the existing literature. Our synthesis shows that proprietary models such as GPT-3.5/4 are the most used for RAG applications in healthcare. Also, there is a lack of standardized evaluation frameworks for RAG-based applications. In addition, the majority of the studies do not assess or address ethical considerations related to RAG in healthcare. It is important to account for ethical challenges that are inherent when AI systems are implemented in the clinical setting. Lastly, we highlight the need for further research and development to ensure responsible and effective adoption of RAG in the medical domain.
- 11 July 2024
- Published by MDPI AG in Preprints.org
Open AccessRetrieval Augmented Generation for Large Language Models in Healthcare: A Systematic Review
Large Language Models (LLMs) have demonstrated promising capabilities to solve complex tasks in critical sectors such as healthcare. However, LLMs are limited by their training data which is often outdated, the tendency to generate inaccurate ("hallucinated") content and a lack of transparency in the content they generate. To address these limitations, retrieval augmented generation (RAG) grounds the responses of LLMs by exposing them to external knowledge sources. However, in the healthcare domain there is currently a lack of systematic understanding of which datasets, RAG methodologies and evaluation frameworks are available. This review aims to bridge this gap by assessing RAG-based approaches employed by LLMs in healthcare, focusing on the different steps of retrieval, augmentation and generation. Additionally, we identify the limitations, strengths and gaps in the existing literature. Our synthesis shows that proprietary models such as GPT-3.5/4 are the most used for RAG applications in healthcare. Also, there is a lack of standardized evaluation frameworks for RAG-based applications. In addition, the majority of the studies do not assess or address ethical considerations related to RAG in healthcare. It is important to account for ethical challenges that are inherent when AI systems are implemented in the clinical setting. Lastly, we highlight the need for further research and development to ensure responsible and effective adoption of RAG in the medical domain.